• Latest Posts

The Largest Deals, Fundraising and Exits of 2016 in European Biotech

These are our 10 Most Read Biotech Articles of 2016

Up, up and away! CureVac’s money pile now Totals €325M

German Biotech allies with Genentech in battle for Cancer Vaccine

mRNA Money-magnet increases its Pile of Cash to over €1.3Bn

ADVERTISEMENT

AstraZeneca plans Phase I trial with mRNA therapy for Cardiovascular Disease

First All-Cancer mRNA Vaccine that Works Published in Nature

German mRNA specialist moves into Animal Health in collaboration with Bayer

What are Money-Magnet Moderna’s future plans? French Founding CEO explains here

What happened this week? mRNA Therapies, TCR & Algae Beer

ADVERTISEMENT